The researchers acknowledged that the symptoms seen in these healthy individuals could differ from those in symptomatic patients.
"On the other hand, rebound acid hypersecretion could be even more relevant in patients with reflux disease or other acid-related disorders," they said, if those patients find it difficult to quit PPIs because of rapid recurrence of symptoms aggravated or even provoked by rebound acid hypersecretion.
Do you have more information about this topic? If so, please click here to contact the editors of ABC News.
